Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4的应助被暖风嘿嘿采纳,获得10
刚刚
顺心绮兰完成签到,获得积分10
刚刚
赵函荧发布了新的文献求助10
刚刚
梦辞发布了新的文献求助10
1秒前
领导范儿的应助被yyy采纳,获得10
1秒前
秋的账号发布了新的文献求助20
1秒前
彭于晏发布了新的文献求助20
2秒前
kangshuai完成签到,获得积分10
3秒前
3秒前
哈哈哈哈完成签到,获得积分10
3秒前
事缓则圆发布了新的文献求助10
4秒前
子见南子完成签到,获得积分20
4秒前
小蔡完成签到 ,获得积分10
4秒前
5秒前
starchaser完成签到,获得积分10
6秒前
在水一方的应助被郑雪红采纳,获得10
6秒前
6秒前
6秒前
7秒前
7秒前
大力的一曲完成签到,获得积分10
7秒前
7秒前
7秒前
犬来八荒发布了新的文献求助10
7秒前
7秒前
ojw21完成签到,获得积分10
8秒前
8秒前
9秒前
Azure完成签到 ,获得积分10
9秒前
9秒前
9秒前
10秒前
可爱的函函的应助被YY采纳,获得10
10秒前
六月发布了新的文献求助10
10秒前
11秒前
缓慢的秋莲完成签到,获得积分10
11秒前
李爱国的应助被无情的哑铃采纳,获得10
11秒前
汉堡包的应助被潇潇雨歇采纳,获得10
12秒前
12秒前
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
Nanocomposite Removal of Pesticides from Wastewater 1000
Practical Manual of Forensic Psychophysiology: Methodology, Execution, and Fields of Application 800
Rosenblum, Global Change Biology 800
Final Report for the 2-D Test of Model 901 Rotor and Wing Airfoils (BSWT 592) 528
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 物理 生物化学 化学工程 内科学 复合材料 催化作用 心理学 人工智能 细胞生物学 光电子学 无机化学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 7907779
求助须知:如何正确求助?哪些是违规求助? 9411659
关于积分的说明 20894245
捐赠科研通 7508060
什么是DOI,文献DOI怎么找? 3361996
关于科研通互助平台的介绍 2499908
邀请新用户注册赠送积分活动 2392237